IMMUNOTHERAPY AGENTS USE FOR TREATMENT OF WARTS.
AG Nasr Hassan, A Nofal… - Journal of …, 2023 - search.ebscohost.com
Background: HPVs infect stratified epithelium and establish infections that can persist for
decades. For these infections to persist, papillomaviruses have evolved strategies to evade …
decades. For these infections to persist, papillomaviruses have evolved strategies to evade …
Human papillomavirus infections: epidemiology, pathogenesis, and therapy
J Severson, TY Evans, P Lee, T Chan, I Arany… - Journal of Cutaneous …, 2001 - Springer
A bstract Background: Human papillomaviruses (HPV) are common human pathogens and
are classified into more than 80 different types. These viruses produce benign warts in many …
are classified into more than 80 different types. These viruses produce benign warts in many …
[PDF][PDF] A fixed herbal combination-A new approach in HPV cervical infection treatment
Out of the large family of human papillomaviruses (HPVs), some viral strains are related to
several types of cutaneous, anogenital and oral mucosa cancers, by developing strategies …
several types of cutaneous, anogenital and oral mucosa cancers, by developing strategies …
[HTML][HTML] Chronic Ulcer on the Tongue as a Manifestation of Histoplasmosis During Anti-tumor Necrosis Factor-Alpha (TNF-⍺) Inhibitor Therapy for Psoriasis
I Harrison, M Forouzandeh, K Motaparthi - Cureus, 2023 - ncbi.nlm.nih.gov
Anti-tumor necrosis factor-alpha (TNF-⍺) inhibitors are commonly used in the treatment of
inflammatory conditions such as psoriasis. However, these agents lead to increased …
inflammatory conditions such as psoriasis. However, these agents lead to increased …
Clinical features and management of genital human papillomavirus infection
JD Oriel - Current Opinion in Infectious Diseases, 1992 - journals.lww.com
New clinical aspects of genital human papillomavirus (HPV) infection are still emerging. The
most interest surrounds subclinical infection, as revealed by magnification after the …
most interest surrounds subclinical infection, as revealed by magnification after the …
Impact of highly active antiretroviral therapy on clinical evolution of genital warts in HIV-1-infected patients
G Orlando, MM Fasolo, R Signori, M Schiavini… - Aids, 1999 - journals.lww.com
Low-risk non-oncogenic human papillomavirus (HPV) genotypes are the aetiologic agents
of anogenital warts, the commonest viral sexually transmitted disease (STD) in the world [1 …
of anogenital warts, the commonest viral sexually transmitted disease (STD) in the world [1 …
Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature
J Zampella, B Cohen - Skin Health and Disease, 2022 - Wiley Online Library
Although the exact mechanisms have yet to be elucidated, it is clear that cellular immunity
plays a role in clearance of human papillomavirus (HPV) infections as it relates to the …
plays a role in clearance of human papillomavirus (HPV) infections as it relates to the …
Therapy for genital human papillomavirus-related disease
CJN Lacey - Journal of Clinical Virology, 2005 - Elsevier
Genital human papillomavirus (HPV) infection is very common, and often sub-clinical and
usually resolves without any treatment. Genital warts are caused by HPV 6/11 infection and …
usually resolves without any treatment. Genital warts are caused by HPV 6/11 infection and …
[PDF][PDF] Psoriasis Vulgaris in Human Immunodeficiency Virus Infected Patient: A
MW Rahmadewi - download.garuda.kemdikbud.go.id
Background: Psoriasis vulgaris (PV) is a chronic inflammatory skin disease characterized by
erythematous thick scaly plaques. PV in human immunodeficiency virus (HIV) infected …
erythematous thick scaly plaques. PV in human immunodeficiency virus (HIV) infected …
[PDF][PDF] Proactive sinecatechins for the treatment of cutaneous HPV related lesions
M Campoli - 2023 - usiena-air.unisi.it
Proactive sinecatechins for the treatment of cutaneous HPV related lesions Page 1 1
DEPARTMENT OF MEDICAL BIOTECHNOLOGIES DOCTORATE in GENETICS, ONCOLOGY …
DEPARTMENT OF MEDICAL BIOTECHNOLOGIES DOCTORATE in GENETICS, ONCOLOGY …